Literature DB >> 17899211

Correlation between finger-prick and venous ciclosporin levels: association with gingival overgrowth and hypertrichosis.

Nicholas J A Webb1, Malcolm G Coulthard, Richard S Trompeter, Margaret M Fitzpatrick, Suzanne Stephens, Jan Dudley, Heather Maxwell, Simon Waller, Graham C Smith, Alan R Watson, David A Hughes, Brian G Keevil, Janice S Ellis.   

Abstract

The aims of this study were (1) to ascertain ciclosporin C(2) levels currently being achieved in children with steroid-sensitive nephrotic syndrome (SSNS) and renal transplants (RTs), (2) to determine the feasibility of the use of finger-prick samples for the measurement of ciclosporin levels, and (3) to identify any correlation between hypertrichosis or gingival overgrowth (GO) and level of ciclosporin 2 h post-dose (C(2)). Seventy-two children (39 with SSNS, 33 with RT) participated. Ciclosporin 12 h trough (C(12)) and C(2) levels were measured in venous and finger-prick samples by high-performance liquid chromatography tandem mass spectroscopy. Photographs of the teeth and back were taken for assessment of GO and hypertrichosis. Mean (+/-SD) C(2) levels in the SSNS and RT groups were 512 (+/-181) microg/l and 471 (+/-229) microg/l. There was a highly significant relationship between venous and finger-prick ciclosporin levels (r(2) = 0.96, P < 0.0001). Fourteen children had severe GO. There was a small, though statistically significant, impact of ciclosporin level on GO (C(2) r(2) = 0.12, P = 0.003 and C(12) r(2) = 0.06, P = 0.038) but no correlation with dose (milligrammes per kilogramme per day or milligrammes per square metre per day) or duration. Seventeen children had moderate or severe hypertrichosis, this being more common in children of South Asian ethnicity (P < 0.0001). There was no correlation between ciclosporin exposure or duration and hypertrichosis. Finger-prick blood sampling may serve as a practical alternative to venepuncture in children receiving ciclosporin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17899211     DOI: 10.1007/s00467-007-0586-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  30 in total

1.  Clinical assessment of body hair growth in women.

Authors:  D FERRIMAN; J D GALLWEY
Journal:  J Clin Endocrinol Metab       Date:  1961-11       Impact factor: 5.958

2.  Risk factors for gingival overgrowth in patients medicated with ciclosporin in the absence of calcium channel blockers.

Authors:  J Mark Thomason; Robin A Seymour; Janice S Ellis
Journal:  J Clin Periodontol       Date:  2005-03       Impact factor: 8.728

Review 3.  Seeking optimal prescription of cyclosporine ME.

Authors:  Matthias Büchler; Atholl Johnston
Journal:  Ther Drug Monit       Date:  2005-02       Impact factor: 3.681

4.  Impact of cyclosporin A pharmacokinetics on the presence of side effects in pediatric renal transplantation.

Authors:  Elias David-Neto; Francine Brambate Carvalhinho Lemos; Erika Arai Furusawa; Benita Soares Schwartzman; Juliana Soares Cavalcante; Elisa Midori Yagyu; Paschoalina Romano; Luis Estevan Ianhez
Journal:  J Am Soc Nephrol       Date:  2000-02       Impact factor: 10.121

5.  Cyclosporin A-induced gingival overgrowth is unrelated to allograft function in renal transplant recipients.

Authors:  D W Thomas; K Baboolal; N Subramanian; R G Newcombe
Journal:  J Clin Periodontol       Date:  2001-07       Impact factor: 8.728

6.  Simultaneous and rapid analysis of cyclosporin A and creatinine in finger prick blood samples using liquid chromatography tandem mass spectrometry and its application in C2 monitoring.

Authors:  Brian G Keevil; David P Tierney; Donald P Cooper; Michael R Morris; Ali Machaal; Nizar Yonan
Journal:  Ther Drug Monit       Date:  2002-12       Impact factor: 3.681

7.  Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation.

Authors:  Richard Trompeter; Guido Filler; Nicholas J A Webb; Alan R Watson; David V Milford; Gunnar Tyden; Ryszard Grenda; Jan Janda; David Hughes; Jochen H H Ehrich; Bernd Klare; Graziella Zacchello; Inge Bjorn Brekke; Mary McGraw; Ferenc Perner; Lucian Ghio; Egon Balzar; Styrbjörn Friman; Rosanna Gusmano; Jochen Stolpe
Journal:  Pediatr Nephrol       Date:  2002-03       Impact factor: 3.714

8.  Cyclosporine therapy monitored with abbreviated area under curve in nephrotic syndrome.

Authors:  Stefano Rinaldi; Antonella Sesto; Paola Barsotti; Tullio Faraggiana; Francesco Sera; Gianfranco Rizzoni
Journal:  Pediatr Nephrol       Date:  2004-11-25       Impact factor: 3.714

9.  Accuracy of cyclosporin measurements made in capillary blood samples obtained by skin puncture.

Authors:  G Merton; K Jones; M Lee; A Johnston; D W Holt
Journal:  Ther Drug Monit       Date:  2000-10       Impact factor: 3.681

10.  Cyclosporin A absorption profiles in pediatric renal transplant recipients predict the risk of acute rejection.

Authors:  Lutz T Weber; Victor W Armstrong; Maria Shipkova; Reinhard Feneberg; Manfred Wiesel; Otto Mehls; Lothar B Zimmerhackl; Michael Oellerich; Burkhard Tönshoff
Journal:  Ther Drug Monit       Date:  2004-08       Impact factor: 3.681

View more
  1 in total

Review 1.  Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC-MS/MS.

Authors:  Mwlod Ghareeb; Fatemeh Akhlaghi
Journal:  Bioanalysis       Date:  2015       Impact factor: 2.681

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.